Date

Thursday, May 20, 2021

Venue

 Fairmont Hotel – Jakarta, Asia Africa street No. 8, Jakarta

Time

10:00 (GMT+7)

Agenda

  1. Approval of the company's Annual Report of the of the financial year 2020, including the company's Activity Report, the Board of Commissioners Oversight Report, as well as the Ratification of the company's Financial Statements 2020.
  2. Approval of the Annual Partnership and Community Development Program (PKBL) Report of the financial year 2020,  and Ratification of the PKBL Financial Report 2020.
  3. Determination on the use of the company net profit of the financial year 2020.
  4. Determination of Salary/Honorarium, Allowances and Facilities for Board of Commissioners and Directors in the financial year 2021 and bonuses in the financial year 2020.
  5. Election of a Public Accountant Firm to audit the company Financial Report and PKBL Reports of the financial year 2021.
  6. Amendments to the company's Articles of Association.
  7. Implementation of the Regulation of the Minister of BUMN RI No.PER-11/MBU/11/2020 regarding Management Contracts and Annual Management Contracts for Directors of State-Owned Enterprises.
  8. Implementation of the Minister of BUMN RI No. PER-1/MBU/03/2021 regarding guidelines for Proposing, Reporting, Monitoring, and Changing the usage of Additional State Equity Participation to State-Owned Enterprises and Limited Liability Companies.
  9. Change of the company management composition

DH/W

원천:
원천 #1
INAF - PT. Indofarma Tbk

Rp 195

-21 (-10,00%)